Shingrix - An Adjuvanted, Recombinant Herpes Zoster Vaccine

被引：0
|
作者：
不详
机构：
来源：
MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 2017年 / 59卷 / 1535期
关键词：
SUBUNIT VACCINE; EFFICACY;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：195 / 196
页数：2
相关论文
共 50 条
  • [31] Herpes Zoster and Varicella Encephalitis Following the Recombinant Zoster Vaccine
    Pane, Mallory
    Harrell, Catherine
    Pickell, Stuart C.
    CUTIS, 2024, 113 (02): : E14 - E15
  • [32] An update on national recommendations for the use of the adjuvanted recombinant zoster vaccine
    Parikh, R.
    Widenmaier, R.
    Weller, R.
    Lecrenier, N.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2022, 32
  • [33] An Exploratory Investigation of Representations of Herpes Zoster and Adjuvanted Recombinant Herpes Zoster Vaccination in a Sample of Fragile Adults in Italy
    De Caro, Francesco
    Pecoraro, Nadia
    Capunzo, Mario
    Caruccio, Simona
    Caggiano, Filippo
    Cersosimo, Giuseppina
    Costantino, Maria
    Longanella, Walter
    Malatesta, Francesca
    Tomeo, Matteo
    Savarese, Giulia
    Sinopoli, Pio
    Vozzella, Emilia Anna
    Moccia, Giuseppina
    PATHOGENS, 2025, 14 (02):
  • [34] Sex, Age, and Previous Herpes Zoster Infection Role on Adverse Events Following Immunization with Adjuvanted Recombinant Vaccine
    Costantino, Maria
    Giudice, Valentina
    Moccia, Giuseppina
    Ragozzino, Monica
    Calabrese, Salvatore
    Caiazzo, Francesco
    Beatrice, Massimo
    Longanella, Walter
    Caruccio, Simona
    Iacuzzo, Candida
    Giugliano, Carmen
    Marongiu, Mariagrazia Bathilde
    Genovese, Giovanni
    Serio, Bianca
    Vozzella, Emilia Anna
    Filippelli, Amelia
    De Caro, Francesco
    PATHOGENS, 2025, 14 (02):
  • [35] Safety and Adverse Events of the Adjuvanted Herpes Zoster Vaccine (Shingrix) in Inflammatory Bowel Disease Patients: A Comparison of Age Groups Under and Over 50 Years
    Kim, D. H.
    Kang, S. B.
    Park, Y. H.
    Kim, K. O.
    Park, S. H.
    Lee, Y. J.
    Moon, W.
    Park, S. J.
    Na, S. Y.
    Kim, E. S.
    Oh, S. J.
    Shin, S. Y.
    IBD Res Grp KASID Korean Assoc Study Intestinal Dis
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1615 - i1617
  • [36] HERPES ZOSTER IN INDIVIDUALS WITH AUTOIMMUNE DISEASES AND RECOMBINANT HERPES ZOSTER VACCINE AS A PREVENTATIVE STRATEGY
    Winthrop, K.
    Farraye, F. A.
    Sullivan, K. M.
    Willer, D. O.
    Vink, P.
    Tavares-Da-Silva, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1655 - 1656
  • [37] Immunogenicity and Safety of the HZ/su Adjuvanted Herpes Zoster Subunit Vaccine in Adults Previously Vaccinated With a Live Attenuated Herpes Zoster Vaccine
    Grupping, Katrijn
    Campora, Laura
    Douha, Martine
    Heineman, Thomas C.
    Klein, Nicola P.
    Lal, Himal
    Peterson, James
    Vastiau, Ilse
    Oostvogels, Lidia
    JOURNAL OF INFECTIOUS DISEASES, 2017, 216 (11): : 1343 - 1351
  • [38] Use of Recombinant Zoster Vaccine (RZV-Shingrix) in Patients With Inflammatory Bowel Disease
    Reich, Jason
    Li Pei-Hsuan
    Zahorian, Toni
    Noronha, Ansu
    Wasan, Sharmeel K.
    Farraye, Francis A.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S400 - S400
  • [39] SAFETY OF RECOMBINANT ZOSTER VACCINE (RZV-SHINGRIX) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Satyam, Venkata R.
    Li, Pei-Hsuan
    Reich, Jason
    Qazi, Taha
    Noronha, Ansu
    Wasan, Sharmeel K.
    Farraye, Francis A.
    GASTROENTEROLOGY, 2019, 156 (06) : S665 - S666
  • [40] Herpes Zoster Following Recombinant Zoster Vaccine With or Without Concomitant Vaccination
    Bruxvoort, Katia J.
    Qian, Lei
    Wu, Jun
    Florea, Ana
    Ackerson, Bradley
    Sy, Lina S.
    Daily, Leticia Vega
    Takhar, Harpreet
    Tseng, Hung Fu
    OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (03):
12345